TIS tissue therapies limited

questions for the agm, page-39

  1. 492 Posts.
    Hi gkm

    SM did respond that there was an expectation of a "few hundred thousand" revenue from VitroGrow sales for calendar 2012. He said that due to the European summer there would be effectively 3 months of sales potential.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.